# Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer

> **NCT03090412** · PHASE2 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 2 (actual)

## Conditions studied

- Stage I Oral Cavity Squamous Cell Carcinoma
- Stage II Oral Cavity Squamous Cell Carcinoma

## Interventions

- **DRUG:** HPPH
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Photodynamic Therapy
- **OTHER:** Quality-of-Life Assessment
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT03090412
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-07
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-08-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2022-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090412, "Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03090412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*